Synmosa Biopharma Corporation (TPEX:4114)
Taiwan · Delayed Price · Currency is TWD 31.75
-0.20 (-0.63%)
Apr 20, 2026, 1:00 PM CST
Synmosa Biopharma Company Description
Synmosa Biopharma Corporation, a specialty pharmaceutical company, engages in the manufacturing and sales of various pharmaceuticals and medical devices in Taiwan, China, the United States, Canada, Thailand, Malaysia, Singapore, and internationally.
It offers medicines for urology, hormones, oncology, dermatology, cardiovascular, CNS, gastrointestinal, and other areas; and effervescent tables, granules, and nasal sprays.
The company is also involved in provision of cosmetics, veterinary drugs, chemical food additives, and beverages; wholesale retail of environmental drugs; and import and export of related businesses.
The company was founded in 1959 and is based in Taipei, Taiwan.
Synmosa Biopharma Corporation
| Country | Taiwan |
| Founded | 1959 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Zhihui Lin |
Contact Details
Address: No. 396 Neihu Road Taipei, 114 Taiwan | |
| Phone | 886 2 8797 7100 |
| Website | synmosa.com.tw |
Stock Details
| Ticker Symbol | 4114 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0004114004 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Zhihui Lin | Chairman, GM, Managerial Officer and President |
| Hong-Qin Bai | Senior Vice President and Finance Officer |
| Jia-Xin Zhang | Senior Vice President |
| Sheng-Ren Yang | Senior Vice President |
| Liyu Huang | Chief Financial Officer |
| Ching-Hua Tsao | Accounting Officer |
| Zen Young | Vice President of Sales - HP, Marketing and Medical |